Jim Simons Tc Bio Pharm (Holdings) PLC Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.26 - $2959.0 $32,480 - $370 Million
124,925 Added 581.72%
146,400 $41,000
Q2 2022

Aug 12, 2022
BUY
$0.34 - $1.67 $7,301 - $35,863
21,475 New
21,475 $8,000

About TC BioPharm (Holdings) plc

TCBP Quotes by TradingView
  • Ticker TCBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,747,700
  • Market Cap $28.2M
  • Description
  • TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19...
More about TCBP
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email